Phathom Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

Phathom Pharmaceuticals

07/11/2024 15:10

* Phathom Pharmaceuticals Inc  PHAT.OQ  reported a quarterly
adjusted loss of $1.32​​ per share for the quarter ended
September 30, lower than the same quarter last year, when the
company reported EPS of -76 cents.  The mean expectation of
seven analysts for the quarter was for a loss of $1.49 per
share. Wall Street expected results to range from $-1.74
to $-1.22 per share.
    * Revenue was $16.35 million​; analysts expected $12.61
million. 
    * Phathom Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $1.32​.
    * The company reported a quarterly loss of $85.58 million.
    * Phathom Pharmaceuticals Inc shares had fallen by 0.4% this
quarter and gained 97.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Phathom
Pharmaceuticals Inc is 24.00 
This summary was machine generated from LSEG data November 7 at
03:10 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -1.49                         
 Jun. 30 2024      -1.38                         
 Mar. 31 2024      -1.31                         
 Dec. 31 2023      -1.08          -1.39          Missed